Overview

Improving Multivitamin Supplementation to Pregnant Women

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the tolerability of Pregvit® to a common prenatal vitamin (Orifer® F) among pregnant women with morning sickness or those suffering from a variety of conditions.
Phase:
Phase 4
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
Duchesnay Inc.